Nabla Secures $70M Series C Funding to Advance AI in Healthcare

Nabla, a leading AI assistant company in the healthcare sector, has successfully raised $70 million in a Series C funding round led by HV Capital. This significant investment brings Nabla's total funding to $120 million, marking a substantial leap from its previous $24 million Series B round in January 2024.
Expansion into Agentic AI
With this new influx of capital, Nabla is set to broaden its horizons beyond its well-known AI-assisted clinical notetaking capabilities. The company has announced plans to develop a range of AI agents designed to automate and streamline various aspects of healthcare workflows:
-
A proactive coding agent to enhance real-time support for ICD-10, HCC, and MCC coding, with future capabilities for evaluation and management (E/M) coding and compliance nudges.
-
A context-aware agent built on Nabla's existing patient summary and pre-charting infrastructure, aimed at providing smarter documentation, initiating orders, and directing electronic health record commands.
-
A custom care setting agent, initially focused on assisting nurses in hospital settings, with the potential for customers to build personalized solutions on top of Nabla's core agents.
Rapid Growth and Industry Impact
Nabla's innovative approach to healthcare AI has led to impressive growth, with the company reporting a fivefold increase in revenue over the past six months. Currently, Nabla's technology is deployed across more than 130 healthcare organizations, including academic medical centers, safety-net hospitals, community health centers, and physician groups nationwide, serving approximately 85,000 clinicians.
Alex Lebrun, CEO and co-founder of Nabla, emphasized the company's evolving vision: "Our vision of what we do has evolved quickly as we discovered the future needs of our customers." This adaptability has allowed Nabla to expand its services beyond clinical documentation to become a comprehensive AI assistant for its partners, helping with pre-charting, coding, and a wide range of specific workflows.
Integration and Future Outlook
Nabla's technology has progressed from being primarily an ambient documentation tool to a fully integrated solution that works across multiple platforms. The company's AI assistants can now interact with various software systems used by healthcare professionals, including electronic health records, revenue cycle management tools, and messaging platforms.
Delphine Groll, Nabla's chief operating officer, expressed confidence in the company's product, inviting prospective customers to conduct head-to-head pilots with competitors. As Nabla continues to innovate and expand its offerings, Lebrun remains optimistic about the future: "It's like a new beginning, where, after we put our foot in the door with documentation, we have so many things to do."
References
- Nabla banks $70M series C to build out agentic AI for clinical workflows
With the infusion of capital, Nabla hopes to bring personalized AI agents to every corner of healthcare, the startup said.
Explore Further
What are the key backgrounds and roles of the executives leading Nabla, including CEO Alex Lebrun and COO Delphine Groll?
How does Nabla's funding history, including this latest $70 million Series C, reflect its growth and future strategy?
What is the estimated market size for AI solutions in the healthcare sector that Nabla is targeting?
Who are the main competitors of Nabla in the field of AI healthcare automation and documentation?
What are the unique features or innovations in Nabla's AI agents that differentiate them from competitors in healthcare?